Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments

Xiaoqiang Tang1, Pei-Heng Li2, Hou-Zao Chen2

  • 1Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China.

Insights

Cardiac aging leads to heart failure through cardiomyocyte senescence and metabolic changes. This review explores cellular communication and metabolic shifts in aging hearts, highlighting key areas for future research.

Area of Science:

  • Cardiovascular Biology
  • Cellular Aging
  • Metabolic Regulation

Background:

  • Cardiovascular diseases are the leading cause of death, with aging as a primary risk factor.
  • Cardiac aging involves cardiomyocyte dysfunction, reduced angiogenesis, and increased fibrosis, leading to heart failure.
  • Senescent cardiomyocytes exhibit DNA damage, mitochondrial dysfunction, and a senescence-associated secreting phenotype (SASP).

Purpose of the Study:

  • To review the hallmarks of cardiomyocyte senescence in cardiac aging.
  • To discuss metabolic alterations in senescent cardiomyocytes.
  • To examine intercellular communication between cardiomyocytes and non-myocytes in the aging heart.

Main Methods:

  • Literature review focusing on cellular and molecular mechanisms of cardiac aging.
  • Analysis of metabolic pathways involved in cardiomyocyte senescence.
  • Examination of paracrine signaling and microenvironmental interactions.

Main Results:

  • Cardiomyocyte senescence is characterized by specific cellular hallmarks and metabolic reprogramming.
  • Interactions between senescent cardiomyocytes and non-myocytes significantly influence cardiac aging.
  • Metabolic regulators in non-myocytes play a crucial role in modulating the myocardial microenvironment.

Conclusions:

  • Cardiomyocyte senescence and altered metabolism are central to cardiac aging and heart failure.
  • Understanding intercellular communication is vital for targeting aging-related cardiovascular dysfunction.
  • Further research is needed to elucidate specific molecular pathways and therapeutic targets.